指南与共识复苏、休克与脓毒症心脑血管急症消化、代谢与肾脏急症

直接口服抗凝药在危重及危及生命出血中的紧急逆转:多学科专家共识

Urgent Reversal of Direct Oral Anticoagulants in Critical and Life-Threatening Bleeding: A Multidisciplinary Expert Consensus.
指南 / 共识 · J Clin Med · 2024-11-14
一句话结论专家共识指出,在严重出血中如假定或证实存在临床相关的DOAC血药浓度,需进行DOAC逆转以恢复止血,并聚焦于选择适合给予特异性逆转剂的患者。

直接口服抗凝药(DOAC)因疗效/安全性比更优且临床和经济负担低于维生素K拮抗剂而应用日增,但出血仍是其最常见并发症,虽罕见却可危及生命或危重。出血事件中DOAC抗凝活性的影响需根据患者临床评估、剂量及末次服药时间、合并症(尤其肾功能和肝功能不全)以及尽可能进行的凝血试验来评估。常规凝血试验不易或通常无法检测DOAC抗凝活性;特异性DOAC检测可进行药物监测,但耗时且常规急诊实践中通常不可用。该专家共识提供了一篇关于DOAC逆转及多种场景(创伤、颅内出血和消化道出血)下危及生命出血实用管理的叙述性综述,重点在于选择应给予特异性逆转剂的患者。

要点

  • 出血事件中DOAC抗凝活性的影响需根据患者临床评估、剂量及末次服药时间、合并症(尤其肾功能和肝功能不全)以及尽可能的凝血试验来评估。
  • 常规凝血试验不易或通常无法检测DOAC抗凝活性;特异性DOAC检测可监测药物,但耗时且常规急诊实践中通常不可用。
  • 如严重出血场景中假定或证实存在临床相关的DOAC血浆浓度,需进行DOAC逆转以恢复止血。
  • 该专家共识聚焦于创伤、颅内出血和消化道出血等场景下危及生命出血的实用管理,重点为选择应给予特异性逆转剂的患者。

适用人群与场景

  • 发生危重或危及生命出血的直接口服抗凝药(DOAC)服用患者,场景包括创伤、颅内出血和消化道出血。

处置流程与药物剂量

  • 如严重出血场景中假定或证实存在临床相关的DOAC血浆浓度,需进行DOAC逆转以恢复止血。

研究设计与关键结果

  • 该多学科专家共识提供了一篇关于DOAC逆转及多种场景(创伤、颅内出血和消化道出血)下危及生命出血实用管理的叙述性综述,重点在于选择应给予特异性逆转剂的患者。

证据类型、等级与局限

  • 证据类型:多学科专家共识(叙述性综述)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 对服用DOAC的危重或危及生命出血患者,应基于临床评估、剂量及末次服药时间、合并症(尤其肾功能和肝功能不全)及尽可能的凝血试验来评估抗凝活性,以识别适合给予特异性逆转剂的患者。

指南或共识出处

  • Urgent Reversal of Direct Oral Anticoagulants in Critical and Life-Threatening Bleeding: A Multidisciplinary Expert Consensus(J Clin Med)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Direct oral anticoagulants (DOACs) are increasingly being used due to their improved efficacy/safety ratio and lower clinical and economic burden when compared to vitamin K antagonists. However, bleeding is still the most frequent complication associated with DOACs, and although rare, bleeding episodes can be life-threatening or critical. The impact of DOAC anticoagulation activity during a bleeding event must be evaluated according to patient clinical assessment, dosage and time from last intake, the presence of comorbidities (especially kidney and liver dysfunction), and, whenever possible, coagulation tests. Unfortunately, DOACs' anticoagulation activity is not easily or usually detectable in routine common coagulation testing. Specific DOAC tests allow for specific drug monitoring, but they are too time consuming, and are usually unavailable in routine emergency practice. If a clinically relevant DOAC plasma concentration is assumed or proven in a severe bleeding scenario, DOAC reversal is needed to restore hemostasis. This experts' consensus provides a narrative review about DOAC reversal and practical life-threatening bleeding management in several scenarios (trauma, intracranial hemorrhage and gastrointestinal bleeding), focusing on the selection of patients to whom specific reversal agents should be given.

来源:J Clin Med,查看原文。版权归原作者所有。

参考来源

  1. Rodrigues A, Gonçalves LR, Gregório T, et al. Urgent Reversal of Direct Oral Anticoagulants in Critical and Life-Threatening Bleeding: A Multidisciplinary Expert Consensus. J Clin Med. 2024. PMID: 39597986. doi:10.3390/jcm13226842

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。